Angiocrine Bioscience: Clinical Trials

7 trials sponsored by Angiocrine Bioscience, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed, 2 recruiting, 1 active not recruiting, 1 not yet recruiting. 5 Phase 1, 1 Phase 2, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 15Completed 2, Recruiting 2, Active not recruiting 1
Phase 21Not yet recruiting 1
Phase 31Terminated 1

Follow Angiocrine Bioscience: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
E-CEL UVEC Cell Injection Treatment of Perianal Fistulas
E-CEL UVEC Cells - Cryptoglandular Perianal Fistula
Phase 2Not yet recruitingAngiocrine Bioscience782027-05-012026-04-29
E-CEL UVEC Treatment for Anal Fissures
E-CEL UVEC cells (AB-207) - Chronic Anal Fissure
Phase 1RecruitingWeill Medical College of Cornell University202024-09-122026-04-08
A Study of the Effects of AB-205 in Patients With Lymphoma Undergoing Autologous Hematopoietic Cell Transplantation
AB-205, Placebo - Hodgkin Lymphoma, Non Hodgkin Lymphoma
Phase 3TerminatedAngiocrine Bioscience1302022-02-212025-02-04
E-CEL UVEC as an Adjunct Cell Therapy for Treatment of Anal Fistulas
E-CEL UVEC - Anal Fistula
Phase 1RecruitingWeill Medical College of Cornell University392020-01-222025-11-18
E-CEL UVEC Cells as an Adjunct Cell Therapy for the Arthroscopic Rotator Cuff Repair in Adults
E-CEL UVEC - Rotator Cuff Tears, Muscle Atrophy or Weakness
Phase 1Active not recruitingHospital for Special Surgery, New York202019-11-202026-08-20
Trial of AB-205 in Adults With Lymphoma Undergoing High-Dose Therapy and Autologous Stem Cell Transplantation
AB-205 - Hodgkin Lymphoma, Non-hodgkin Lymphoma
Phase 1CompletedAngiocrine Bioscience422019-05-072022-03-03
Trial of AB-110 in Adults With Hematologic Malignancies Undergoing Cord Blood Transplantation
Unmanipulated Umbilical Cord Blood (UCB), AB-110 - Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia in Remission
Phase 1CompletedAngiocrine Bioscience102018-04-242022-05-31

Conditions studied

Hodgkin Disease (2)  ·  Lymphoma, Non-Hodgkin (2)  ·  Asthenia (1)  ·  Leukemia, Myeloid, Acute (1)  ·  Lymphoma (1)  ·  Muscular Atrophy (1)  ·  Myelodysplastic Syndromes (1)  ·  Rectal Fistula (1)  ·  Rotator Cuff Injuries (1)

Interventions

epithienamycin E (1)

Countries

United States (7)

Top investigators

Paul Finnegan, MD (3)  ·  Jeffrey W Milsom, MD (1)  ·  Kelly Garrett, MD (1)  ·  Scott Rodeo, MD (1)